Schedule a Call

Building Editorial Systems for Life Sciences Organizations

~80%

of health system executives expect gen AI proliferation to have significant or moderate impact on their organizations in 2025 [1]
15%

of LSHC executives say their organizations have adapted governance to keep pace with AI — a critical gap for content oversight [2]
38%

of organizations cite regulatory compliance as the top obstacle to deploying gen AI in content and operational workflows [3]

What an Editorial System Is — and Is Not

An editorial system is the combination of processes, governance structures, tools, and standards that enable an organization to produce content reliably, accurately, and at scale. It is distinct from a content strategy (which defines what content to produce and why) and a content calendar (which plans what will be produced when). An editorial system defines how production actually happens.

In life sciences and digital health contexts, editorial systems must address two requirements that general content frameworks often ignore: accuracy verification (content must be factually correct and scientifically sound) and compliance review (content must meet regulatory, legal, and MLR requirements before publication). These requirements add complexity that must be designed into the editorial system from the outset.

The Five Layers of an Editorial System

Layer 1: Content Governance

Governance defines who has authority over content decisions, how disputes are resolved, and how the editorial system itself is maintained. In life sciences, governance typically involves representation from medical, legal, regulatory, commercial, and marketing functions. Clear governance prevents the most common editorial bottleneck: reviews that stall because ownership and authority are ambiguous.

Layer 2: Content Architecture

Content architecture defines the taxonomy of content types your organization produces, the structural template for each type, and the review and approval requirements that apply to each. A well-designed content architecture eliminates thousands of micro-decisions from the production process by answering common questions once, systematically.

A pharmaceutical commercial organization might define five to ten content types — detail aids, patient education brochures, HCP email sequences, medical congress presentations, digital banner ads — each with its own structure template, required review checklist, and approval workflow.

Layer 3: Production Workflow

The production workflow defines the step-by-step process from content brief to published asset, including the roles responsible at each step, the criteria for advancing to the next step, and the escalation paths for items that fail criteria.

Brief

Objectives, audience, key messages

Draft

Writer produces first draft to template

Editorial Review

Accuracy, structure, tone

MLR Review

Medical / Legal / Regulatory

Final Approval

Designated authority sign-off

Publish

Distribution & tracking

Layer 4: Review and Approval Infrastructure

In life sciences, the review and approval layer is where most editorial system failures occur. Organizations that have not intentionally designed this layer typically develop informal, inconsistent patterns: reviews requested by email, feedback delivered in unstructured comments, approval records scattered across individuals’ sent folders.

A well-designed review infrastructure includes: a designated workflow tool that routes content to reviewers and tracks status, standardized review checklists for each content type and reviewer role, a clear protocol for managing conflicting feedback, a formal approval record documenting who approved what and when, and version control ensuring reviewers always work on the current draft.

Sakara Digital Perspective: The review and approval layer is the highest-value investment in editorial system design for life sciences organizations. Reducing average MLR cycle time by even three to five business days across a high-volume content operation can unlock significant commercial velocity — and the investment required is primarily process design, not technology procurement.

Layer 5: Content Maintenance and Retirement

Published content does not stay accurate indefinitely. Clinical data updates, regulatory guidance changes, label revisions, and market access shifts can all render previously approved content outdated or non-compliant. An editorial system must include a mechanism for tracking published content, triggering reviews when relevant changes occur, and retiring content that has passed its useful life or accuracy threshold.

AI’s Role in Modern Editorial Systems

Editorial Stage AI Application Human Role Preserved
Brief Development Drafting brief templates from strategy documents; summarizing reference materials Strategic direction, audience insight, business context
First Draft Production Generating structured first drafts from approved briefs and reference materials Voice, nuance, scientific accuracy judgment, brand alignment
Editorial Review Automated checking against style guide, structure template, required elements Substantive accuracy, tone, clarity, strategic alignment
Reference Verification Automated checking that claims are supported by cited references Interpretation of ambiguous or context-dependent claims
Maintenance Monitoring Automated alerts when referenced guidelines or data are updated Assessment of whether update affects content accuracy

Implementation Approach

Phase 1 — Diagnosis and Design (4–6 weeks): Audit current content production processes, identify pain points and bottlenecks, define content types and governance structure, draft production workflow and review infrastructure designs. Involve key stakeholders from all review functions in co-designing the system.

Phase 2 — Piloting and Refinement (6–8 weeks): Pilot the new system with a defined subset of content. Measure cycle time, review iteration rates, and stakeholder satisfaction. Collect structured feedback and refine the system before full deployment.

Phase 3 — Full Deployment and Optimization (Ongoing): Roll out the system organization-wide. Train all participants. Monitor performance metrics. Review and refine quarterly as volume, content types, and regulatory requirements evolve.

Conclusion

An effective editorial system is one of the highest-leverage investments a life sciences or digital health organization can make in its content capability. It reduces cost per asset, accelerates time-to-market, improves quality and consistency, and manages compliance risk systematically.

The investment is primarily in design, process, and change management — not technology. Organizations that approach editorial system development with the same rigor they apply to other operational systems consistently outperform those that try to solve content production challenges with tools alone.

References & Sources

  1. 2025 Global Health Care Executive Outlook — Deloitte.
  2. Life Sciences and Health Care Industry Insights Report 2026 — Deloitte, November 2025.
  3. State of Gen AI in the Enterprise — Fourth Wave — Deloitte AI Institute, January 2025.
  4. Draft Guidance: AI to Support Regulatory Decision-Making — U.S. FDA, January 2025.
  5. EU AI Act — European Commission, August 2024.

#SakaraDigital #ContentOperations #LifeSciences #EditorialSystems #RegulatoryContent



Your perspective matters—join the conversation.

Discover more from Sakara Digital

Subscribe now to keep reading and get access to the full archive.

Continue reading